S.A.L.T
S.A.L.T is a point of care medical device that rapidly & reliably measures salt levels in urine using 2 urine strips and a mobile app. S.A.L.T Team: Fantasia Powell, Founder Eliot Kim, Advisor
Read MoreMySmileBuddy
MySmileBuddy’s interactive tablet-based educational and action-planning technology supports parent/lay health worker dyads in managing risks for early childhood tooth decay consistent with current best science. MySmileBuddy Team: Burton L. Edelstein, DDS MPH, CEO Christie Custodio-Lumsden, PhD, COO
Read MoreZakan Theraputics
Zakan Therapeutics — A biological therapeutic that can directly attack metastatic cancer cells by delivering a payload of anti-cancer compounds while bypassing healthy cells. Zakan Theraputics Team: Arthee Jahangir Benjamin Caballero
Read MoreJotteq
Jot is a new kind of eye drop dispenser that is safe and easy to use. My objective is to bring it to market Jotteq Team: Nigel Kelly
Read MoreIchor Biologics
A validated platform for the isolation of human monoclonal antibodies (mAbs), which neutralize emerging and re-emerging infectious diseases. Ichor Biologics Team: Raymond Alvarez Justin Ring
Read MoreInnovene, Inc.
Innovene has designed a new class of medications from safe plant-derived components; TriCurin will target the unmet medical need of treating patients with oncogenic human papillomavirus infections. Innovene Team: Mario Castellanos, MD, Co-Founder and President Alia Kozlova
Read MoreBioharmony Therapy
Bioharmony Therapeutics is an early-stage biotech startup focused on the development of first-in-class antimicrobials that target infections caused by Gram-negative bacteria. Bioharmony Theraputics Team: Chandrabali Ghose-Paul, Founder and CEO
Read MoreChemitope Glycopeptide
Chemitope specializes in the chemical synthesis of complex glycopeptides for use in challenging vaccine applications, such as HIV. Team: Baptiste Aussedat, PhD William Walkowicz, PhD
Read MoreLysimmune BioScience
Platform technology to produce recombinant therapeutic antibodies against Staphylococcus aureus and other pathogens, targeting cell wall carbohydrates not adequately recognized by the human immune system. Team: Assaf Raz, PhD – CSO Vincent A. Fischetti, PhD – Head of SAB
Read MoreCatheCare
CatheCare’s CASS device uses ultraviolet light to prevent the deadly catheter-related infection. Team: Aonnicha Burapachaisr – CEO Chanond Sophonpanich – COO
Read More